Factors that impact initiation of pain management agreements for patients on chronic opioid therapy

Katherine Gonzalez; Alejandro Villasante-Tezanos; Gulshan Sharma; Gulshan Doulatram; Stephen B. Williams; Erin L. Hommel

doi:10.5055/jom.0816

Authors

Katherine Gonzalez, BS https://orcid.org/0000-0002-6458-2420
Alejandro Villasante-Tezanos, PhD https://orcid.org/0000-0001-5108-8637
Gulshan Sharma, MD, MPH https://orcid.org/0000-0002-5339-0087
Gulshan Doulatram, MD https://orcid.org/0000-0002-7725-8574
Stephen B. Williams, MD, MS https://orcid.org/0000-0002-2683-2185
Erin L. Hommel, MD https://orcid.org/0000-0003-1975-4008

DOI:

https://doi.org/10.5055/jom.0816

Keywords:

pain management agreement, chronic pain, opioid therapy

Abstract

Objective: This analysis seeks to understand variables within our institution that impact pain management agreement (PMA) utilization for chronic noncancer pain (CNCP).

Design: Retrospective chart review.

Setting: Public academic medical center.

Patients: Adults prescribed an opioid for CNCP between July 2020 and October 2020.

Main outcome measure: We assessed the association between patient demographics, prescription factors, and prescriber factors with the presence of a PMA. Unadjusted rates and chi-square tests were generated for each predictor. Additionally, we performed two multivariable logistic regressions: one including all variables and another utilizing a stepwise forward variable selection process to further understand the relationships between predictors and the presence of a PMA.

Results: 49.7 percent of patients who received an opioid for CNCP had a PMA on file. One significant predictor of the presence of PMA was prescriber specialty with anesthesia/pain medicine, demonstrating 88 percent compliance. Compared to anesthesia/pain medicine, patients receiving opioids from internal medicine had an odds ratio (OR) of 0.155 (95 percent confidence interval (CI), 0.109-0.220), while patients receiving opioids from family medicine had an OR of 0.122 (95 percent CI, 0.090-0.167). Additionally, patients who received schedule II opioids (as opposed to schedule III/IV opioids), patients with multiple opioid fills in 3 months, middle aged patients, and Black patients were more likely to have a PMA.

Conclusions: Compliance with PMA within our institution was only 49 percent despite an existing state law mandating use. Our analysis suggests quality improvement interventions should target patients on schedule III/IV opioids who receive their prescriptions from primary care providers.

Author Biographies

Katherine Gonzalez, BS

School of Medicine, The University of Texas Medical Branch, Galveston, Texas

Alejandro Villasante-Tezanos, PhD

Assistant Professor, Department of Preventative Medicine and Population Health, The University of Texas Medical Branch, Galveston, Texas

Gulshan Sharma, MD, MPH

Professor, Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, The University of Texas Medical Branch, Galveston, Texas

Gulshan Doulatram, MD

Professor, Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas

Stephen B. Williams, MD, MS

Professor, Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, Texas

Erin L. Hommel, MD

Associate Professor, Department of Internal Medicine, Division of Geriatrics and Palliative Medicine, The University of Texas Medical Branch, Galveston, Texas

References

Centers for Medicare and Medicaid Services: CMS roadmap strategy to fight the opioid crisis. Available at https://www.cms.gov/About-CMS/Agency-Information/Emergency/Downloads/Opioid-epidemic-roadmap.pdf. Accessed February 6, 2022.

Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-130.e22. DOI: https://doi.org/10.1016/j.jpain.2008.10.008

Dowell D, Haegerich TM, Chou R: CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016; 315: 1624-1645. DOI: https://doi.org/10.1001/jama.2016.1464

Federation of State Medical Boards: Guidelines for the chronic use of opioid analgesics. Available at https://www.fsmb.org/siteassets/advocacy/policies/opioid_guidelines_as_adopted_april-2017_final.pdf. Accessed February 6, 2022.

Teitelbaum J, Rosenbaum S: Gonzales v. Oregon: Implications for public health policy and practice. Public Health Rep. 2007; 122: 122-124. DOI: https://doi.org/10.1177/003335490712200117

Federation of State Medical Boards: Pain management policies board by board overview. Available at https://www.fsmb.org/siteassets/advocacy/key-issues/pain-management-by-state.pdf. Accessed February 6, 2022.

National Alliance for Model State Drug Laws: Overview of state pain management and prescribing policies. Available at https://namsdl.org/wp-content/uploads/Overview-of-State-Pain-Management-and-Prescribing-Policies-1.pdf. Accessed February 6, 2022.

Texas Administrative Code: Rule 1703 minimum requirements for the treatment of chronic pain. Available at https://texreg.sos.state.tx.us/public/readtac$ext.TacPage?sl=R&app=9&p_dir=&p_rloc=&p_tloc=&p_ploc=&pg=1&p_tac=&ti=22&pt=9&ch=170&rl=3. Accessed February 6, 2022.

Wong R, Carroll W, Muttreja A, et al.: Improving opioid management and resource utilization in an internal medicine residency clinic: A before-after study over two plan-do-study-act cycles. Pain Med. 2019; 20: 1919-1924. DOI: https://doi.org/10.1093/pm/pny239

Kay C, Wozniak E, Koller S, et al.: Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic. J Opioid Manag. 2016; 12: 333-345. DOI: https://doi.org/10.5055/jom.2016.0350

Kay C, Wozniak E, Ching A, et al.: Pain agreements and healthcare utilization in a veterans affairs primary care population: A retrospective chart review. Pain Ther. 2018; 7: 121-126. DOI: https://doi.org/10.1007/s40122-018-0098-5

Texas Administrative Code: Prescription of controlled substances pain management definitions rule 1702. Available at https://texreg.sos.state.tx.us/public/readtac$ext.TacPage?sl=R&app=9&p_dir=&p_rloc=&p_tloc=&p_ploc=&pg=1&p_tac=&ti=22&pt=9&ch=170&rl=2. Accessed February 6, 2022.

United States Drug Enforcement Administration: Drug scheduling. Available at https://www.dea.gov/drug-information/drug-scheduling. Accessed February 6, 2022.

Oregon Pain Guidance: Opioid conversion calculator. Available at https://www.oregonpainguidance.org/opioidmedcalculator/. Accessed February 6, 2022.

Substance Abuse and Mental Health Services Administration: Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. Available at https://www.samhsa.gov/data/report/2017-nsduh-annual-national-report. Accessed February 6, 2022.

Breuer B, Cruciani R, Portenoy RK: Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: A national survey. South Med J. 2010; 103: 738-747. DOI: https://doi.org/10.1097/SMJ.0b013e3181e74ede

Fishman SM, Mahajan G, Jung SW, et al.: The trilateral opioid contract bridging the pain clinic and the primary care physician through the opioid contract. J Pain Symptom Manage. 2002; 24: 335-344. DOI: https://doi.org/10.1016/S0885-3924(02)00486-4

Laks J, Alford DP, Patel K, et al.: A national survey on patient provider agreements when prescribing opioids for chronic pain. J Gen Intern Med. 2021; 36: 600-605. DOI: https://doi.org/10.1007/s11606-020-06364-2